Skip to content
Clinical Trials – home

Hospital De Sagunto

Research site

Spain Calle De Ramon Y Cajal 46, 46520 Sagunto, Spain

  • 4 trials recruiting
  • IgA nephropathy · Asthma · Breast cancer
  • Adults and children

About Specializations

Hospital De Sagunto in Sagunto, Spain specialises in clinical trials of conditions such as IgA nephropathy, Asthma, Breast cancer, Conjunctivitis allergic, and other specialisations. This site conducts important research.

Main research areas of the site

Digestive System Diseases

At Hospital De Sagunto’s intensive care unit, researchers are investigating new therapeutic options for chronic inflammatory bowel conditions.

  • Long‑term efficacy of monoclonal antibody
  • Safety monitoring in chronic use
  • Patient‑reported outcome assessments

The primary goal is to determine whether long‑term use of a novel monoclonal antibody can improve disease control in patients with ulcerative colitis, while monitoring safety and quality of life.

Immune System Diseases

The ICU team is focused on autoimmune kidney diseases, testing agents that may halt disease progression.

  • Complete renal response evaluation
  • Proteinuria reduction strategies
  • Safety profile of oral inhibitors

Trials aim to achieve a complete renal response in individuals with lupus nephritis and to reduce protein loss in those with Immunoglobulin A nephropathy, thereby preserving kidney function.

Neoplasms

Early‑stage breast cancer patients are enrolled to assess innovative strategies that could lower recurrence risk.

  • Circulating tumor DNA as MRD marker
  • Adjuvant therapy effectiveness
  • Disease clearance rates

By measuring minimal residual disease through circulating tumor DNA, the study seeks to demonstrate that targeted therapy can improve outcomes for breast cancer patients.

Respiratory Tract Diseases

Allergic airway disorders are being treated with novel immunotherapy approaches designed for long‑term symptom relief.

  • Subcutaneous polymerised allergen extracts
  • Placebo‑controlled symptom scoring
  • Impact on asthma control

The investigation compares subcutaneous polymerised extracts with placebo to evaluate symptom reduction in allergic rhinitis and its effect on coexisting asthma.

Pathological Conditions, Signs and Symptoms

Critical care research at the site aims to improve weaning strategies for patients dependent on ventilatory support.

  • Predictors of successful extubation
  • Non‑invasive ventilation vs high‑flow oxygen
  • Standardised weaning protocols

The objective is to lower the rate of extubation failure and to define optimal protocols for transitioning from mechanical ventilation to spontaneous breathing.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Calle De Ramon Y Cajal 4646520 SaguntoSpain
Recruiting now
4 trials
Conditions studied
9

More sites in SaguntoSpain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

8 clinical trials

IgA nephropathy

Recruiting

Study on Atrasentan for Patients with IgA Nephropathy at Risk of Kidney Function Loss

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Zigakibart
  • Sponsor:Novartis Pharma AG

Weaning failure

Recruiting

Study Comparing Non-Invasive Ventilation and High Flow Oxygen Therapy for Patients at Risk of Breathing Support Failure After Ventilator Removal

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Oxygen
  • Sponsor:Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB

Breast cancer

Recruiting

Long-Term Study on Early Stage Breast Cancer Patients Using Capecitabine, Gemcitabine, and Paclitaxel

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer De Mama

Study on the Effectiveness of Abemaciclib, Inavolisib, and Giredestrant in Patients with Early HR-positive/HER2-negative Breast Cancer

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Medica Scientia Innovation Research S.L.

Conjunctivitis allergic+3

Not recruiting

Study on the Effectiveness and Safety of Clustoid MM09 for Patients with Allergic Rhinitis or Rhinoconjunctivitis, with or without Mild to Moderate Asthma

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dermatophagoides Farinae Allergoid, Glutaraldehyde-Modified
  • Sponsor:Inmunotek S.L.

IgA nephropathy

Not recruiting

Study on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Travere Therapeutics Inc.

Lupus nephritis

Not recruiting

Study on the Effectiveness and Safety of Iptacopan with Drug Combination for Adults with Active Lupus Nephritis Class III-IV, +/- V

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Iptacopan
  • Sponsor:Novartis Pharma AG
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.